-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

John Kulze, MD

Articles by John Kulze, MD

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

ByWilliam C. Stewart, MD,Jessica Leech, BS,Elizabeth D. Sharpe, MD,John Kulze, MD,John Ellyn, MD,Douglas G. Day, MD

August 1st 2002

Latest Updated Articles

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension
August 1st 2002

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups

SGLT2 Inhibitors Tied to Lower Platelet Activation in HFrEF

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

Health Care Spending to Hit $9 Trillion by 2034, According to New Analysis